Norwich, Connecticut, USA & Morepeth, Northumberland, UK — December 28, 2007 — Mystic Management Systems, Inc., a leading provider of quality and specification management software solutions, has been selected by NPIL Pharma of Nicholas Piramal India Limited, to supply the Morepeth production facility with Mystic Management Systems’ ensur for Document Control and Quality Management Services.
NPIL Pharma is a leading global custom manufacturer in the pharmaceutical industry. The NPIL Pharma facility at Morepeth, Northumberland, UK, is a 450 person high quality and integrated global manufacturing facility. Their personnel have experience with new product launches, existing product manufacturing, and R&D batching. The Morepeth facility is both USFDA and UKMHRA certified. The NPIL Pharma Morepeth facility is a hub in the global supply of pharmaceuticals to Europe, Japan, and the United States.
About NPIL
Nicholas Piramal India Limited ("NPIL") is one of India's largest pharmaceutical companies with a growth track record of above 25% CAGR since 1988. The Company is currently ranked 4th in the Indian market with a diverse product portfolio spanning nine therapeutic areas. NPIL's had consolidated Revenues of US$352 million in 2005-06. The Company has R&D capabilities in Custom Chemical Synthesis, Process Innovation, NDDS and Basic Research. It has world-class formulations facilities and USFDA-approved API facilities without any 483s.
NPIL has a long track record of successful collaboration with innovator companies. Since 2003, the Company has made significant investments to become a global custom manufacturing organisation (“CMO") for large and medium-sized innovator companies. Nicholas Piramal has a global CMO footprint across North America, Europe & Asia, and is committed to respecting Intellectual Property.
NPIL is listed in India on the Bombay Stock Exchange, National Stock Exchange and Ahmedabad Stock Exchange. For further information, please mail investorrelations@
or visit www.nicholaspiramal.com
